Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Residence Characteristics | 6 | 2017 | 220 | 1.610 |
Why?
|
| Nursing Homes | 18 | 2025 | 666 | 1.600 |
Why?
|
| Pediatric Obesity | 3 | 2016 | 109 | 1.240 |
Why?
|
| Environment | 3 | 2017 | 122 | 1.000 |
Why?
|
| Body Mass Index | 5 | 2017 | 863 | 0.920 |
Why?
|
| Stroke | 13 | 2023 | 1191 | 0.860 |
Why?
|
| Health Status | 3 | 2021 | 435 | 0.850 |
Why?
|
| Mexican Americans | 7 | 2015 | 14 | 0.700 |
Why?
|
| Food Supply | 2 | 2017 | 53 | 0.620 |
Why?
|
| Statistics as Topic | 1 | 2017 | 147 | 0.520 |
Why?
|
| Fast Foods | 1 | 2016 | 13 | 0.500 |
Why?
|
| Models, Statistical | 3 | 2016 | 308 | 0.500 |
Why?
|
| Feeding and Eating Disorders | 3 | 2022 | 49 | 0.500 |
Why?
|
| United States | 24 | 2025 | 7822 | 0.500 |
Why?
|
| Male | 44 | 2025 | 29717 | 0.490 |
Why?
|
| Environment Design | 1 | 2016 | 22 | 0.490 |
Why?
|
| Medicare | 8 | 2025 | 610 | 0.490 |
Why?
|
| Female | 45 | 2025 | 32707 | 0.480 |
Why?
|
| Frailty | 3 | 2022 | 130 | 0.470 |
Why?
|
| Aged, 80 and over | 22 | 2025 | 5429 | 0.450 |
Why?
|
| California | 7 | 2017 | 174 | 0.440 |
Why?
|
| Brain Ischemia | 5 | 2017 | 417 | 0.440 |
Why?
|
| Aged | 30 | 2025 | 14332 | 0.440 |
Why?
|
| Models, Theoretical | 1 | 2016 | 268 | 0.430 |
Why?
|
| Humans | 59 | 2025 | 63146 | 0.430 |
Why?
|
| Memantine | 2 | 2024 | 23 | 0.430 |
Why?
|
| Epidemics | 1 | 2013 | 24 | 0.410 |
Why?
|
| Cognitive Dysfunction | 3 | 2022 | 332 | 0.410 |
Why?
|
| Arthritis, Psoriatic | 2 | 2023 | 32 | 0.400 |
Why?
|
| Health Behavior | 1 | 2016 | 466 | 0.380 |
Why?
|
| Analgesics, Opioid | 4 | 2025 | 533 | 0.380 |
Why?
|
| Schools | 5 | 2017 | 166 | 0.370 |
Why?
|
| Spondylarthritis | 2 | 2023 | 39 | 0.360 |
Why?
|
| Antirheumatic Agents | 2 | 2024 | 219 | 0.350 |
Why?
|
| Atrial Fibrillation | 3 | 2024 | 837 | 0.330 |
Why?
|
| Child | 11 | 2024 | 4520 | 0.330 |
Why?
|
| Depression | 3 | 2025 | 890 | 0.330 |
Why?
|
| Cross-Sectional Studies | 12 | 2025 | 2573 | 0.320 |
Why?
|
| Schizophrenia | 2 | 2021 | 265 | 0.310 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2023 | 334 | 0.310 |
Why?
|
| Drug Prescriptions | 2 | 2021 | 167 | 0.310 |
Why?
|
| Physical Fitness | 3 | 2017 | 91 | 0.310 |
Why?
|
| Pain | 3 | 2025 | 404 | 0.280 |
Why?
|
| Middle Aged | 22 | 2025 | 17477 | 0.280 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2024 | 47 | 0.270 |
Why?
|
| Sexism | 2 | 2024 | 31 | 0.260 |
Why?
|
| Sex Factors | 7 | 2024 | 978 | 0.260 |
Why?
|
| Delirium | 2 | 2025 | 54 | 0.250 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2017 | 126 | 0.250 |
Why?
|
| Stroke Rehabilitation | 2 | 2017 | 50 | 0.240 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2024 | 204 | 0.240 |
Why?
|
| Social Isolation | 1 | 2025 | 36 | 0.240 |
Why?
|
| Adolescent | 9 | 2024 | 6229 | 0.240 |
Why?
|
| Anticoagulants | 3 | 2024 | 495 | 0.240 |
Why?
|
| Multimorbidity | 1 | 2025 | 48 | 0.230 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 834 | 0.230 |
Why?
|
| Physical Education and Training | 2 | 2017 | 28 | 0.230 |
Why?
|
| Communication Barriers | 1 | 2025 | 67 | 0.230 |
Why?
|
| Regression Analysis | 5 | 2017 | 498 | 0.220 |
Why?
|
| Risk Factors | 11 | 2024 | 5329 | 0.220 |
Why?
|
| Insurance, Health | 2 | 2022 | 152 | 0.220 |
Why?
|
| Retrospective Studies | 10 | 2025 | 6596 | 0.210 |
Why?
|
| Frail Elderly | 2 | 2022 | 109 | 0.210 |
Why?
|
| Texas | 7 | 2017 | 57 | 0.210 |
Why?
|
| Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2023 | 10 | 0.210 |
Why?
|
| Hospices | 1 | 2023 | 35 | 0.200 |
Why?
|
| Restaurants | 2 | 2013 | 12 | 0.200 |
Why?
|
| Dementia | 2 | 2024 | 257 | 0.190 |
Why?
|
| Hospice Care | 1 | 2023 | 65 | 0.190 |
Why?
|
| Bulimia | 1 | 2022 | 17 | 0.190 |
Why?
|
| Rheumatology | 1 | 2022 | 67 | 0.190 |
Why?
|
| Prescription Drug Misuse | 1 | 2022 | 20 | 0.190 |
Why?
|
| Activities of Daily Living | 4 | 2017 | 291 | 0.180 |
Why?
|
| Antipsychotic Agents | 1 | 2024 | 301 | 0.180 |
Why?
|
| Geography, Medical | 1 | 2021 | 5 | 0.180 |
Why?
|
| Age Factors | 7 | 2022 | 1559 | 0.180 |
Why?
|
| Quality of Life | 2 | 2021 | 1223 | 0.180 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 129 | 0.180 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2022 | 477 | 0.170 |
Why?
|
| Gender Identity | 1 | 2021 | 67 | 0.170 |
Why?
|
| Young Adult | 7 | 2024 | 4671 | 0.170 |
Why?
|
| Multiple Myeloma | 1 | 2025 | 349 | 0.170 |
Why?
|
| Psychotic Disorders | 1 | 2021 | 158 | 0.160 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2021 | 715 | 0.160 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 163 | 0.160 |
Why?
|
| Cohort Studies | 5 | 2024 | 2560 | 0.160 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 217 | 0.160 |
Why?
|
| Anticonvulsants | 1 | 2020 | 107 | 0.160 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 216 | 0.150 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 130 | 0.150 |
Why?
|
| Mental Health Services | 1 | 2022 | 287 | 0.150 |
Why?
|
| Overweight | 2 | 2012 | 250 | 0.150 |
Why?
|
| Epilepsy | 1 | 2020 | 113 | 0.150 |
Why?
|
| Fibrinolytic Agents | 2 | 2017 | 169 | 0.150 |
Why?
|
| Cluster Analysis | 2 | 2023 | 261 | 0.150 |
Why?
|
| Drug Utilization | 1 | 2020 | 208 | 0.150 |
Why?
|
| Adult | 11 | 2024 | 16732 | 0.140 |
Why?
|
| Hypertension | 3 | 2021 | 584 | 0.140 |
Why?
|
| Minority Groups | 1 | 2019 | 139 | 0.140 |
Why?
|
| Substance-Related Disorders | 2 | 2022 | 732 | 0.140 |
Why?
|
| Guideline Adherence | 3 | 2017 | 306 | 0.140 |
Why?
|
| Comorbidity | 4 | 2025 | 1118 | 0.140 |
Why?
|
| Health Status Disparities | 2 | 2024 | 145 | 0.130 |
Why?
|
| Students | 1 | 2019 | 217 | 0.130 |
Why?
|
| Community-Based Participatory Research | 1 | 2017 | 49 | 0.130 |
Why?
|
| Propensity Score | 1 | 2017 | 155 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 721 | 0.130 |
Why?
|
| Cognition Disorders | 2 | 2017 | 217 | 0.130 |
Why?
|
| Prevalence | 4 | 2025 | 1375 | 0.130 |
Why?
|
| Spatial Analysis | 1 | 2016 | 12 | 0.120 |
Why?
|
| Socioeconomic Factors | 4 | 2021 | 777 | 0.120 |
Why?
|
| Community Health Services | 1 | 2017 | 129 | 0.120 |
Why?
|
| Recovery of Function | 2 | 2015 | 286 | 0.120 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 356 | 0.120 |
Why?
|
| Noninvasive Ventilation | 1 | 2016 | 70 | 0.120 |
Why?
|
| Bias | 1 | 2016 | 112 | 0.120 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 190 | 0.120 |
Why?
|
| Hospitalization | 1 | 2022 | 1356 | 0.120 |
Why?
|
| Linear Models | 1 | 2016 | 408 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2022 | 788 | 0.110 |
Why?
|
| Social Support | 1 | 2017 | 371 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 913 | 0.110 |
Why?
|
| Population Surveillance | 4 | 2017 | 206 | 0.110 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 337 | 0.110 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 96 | 0.110 |
Why?
|
| Obesity | 2 | 2013 | 1230 | 0.110 |
Why?
|
| Treatment Outcome | 6 | 2024 | 5625 | 0.100 |
Why?
|
| Health Promotion | 1 | 2017 | 494 | 0.100 |
Why?
|
| Administration, Oral | 2 | 2024 | 369 | 0.100 |
Why?
|
| Patient Discharge | 3 | 2022 | 510 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2022 | 3270 | 0.100 |
Why?
|
| Telemedicine | 1 | 2017 | 323 | 0.100 |
Why?
|
| Diet | 1 | 2016 | 524 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 263 | 0.090 |
Why?
|
| Policy | 1 | 2012 | 54 | 0.090 |
Why?
|
| Physical Examination | 2 | 2022 | 112 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 502 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 476 | 0.090 |
Why?
|
| Geriatric Assessment | 2 | 2022 | 163 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 1543 | 0.090 |
Why?
|
| Self Report | 2 | 2025 | 374 | 0.080 |
Why?
|
| Legislation, Food | 1 | 2010 | 4 | 0.080 |
Why?
|
| Nutritional Requirements | 1 | 2010 | 20 | 0.080 |
Why?
|
| Ambulatory Care | 2 | 2022 | 311 | 0.080 |
Why?
|
| Beverages | 1 | 2010 | 67 | 0.080 |
Why?
|
| Food | 1 | 2010 | 77 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 1254 | 0.080 |
Why?
|
| School Health Services | 1 | 2010 | 71 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 2452 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2022 | 769 | 0.070 |
Why?
|
| Incidence | 3 | 2015 | 1373 | 0.060 |
Why?
|
| Cognition | 2 | 2023 | 484 | 0.060 |
Why?
|
| Pregnancy | 2 | 2023 | 2326 | 0.060 |
Why?
|
| SEER Program | 1 | 2025 | 74 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2025 | 114 | 0.060 |
Why?
|
| Comparative Effectiveness Research | 1 | 2024 | 46 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2025 | 345 | 0.050 |
Why?
|
| Language | 1 | 2025 | 149 | 0.050 |
Why?
|
| Population Health | 1 | 2024 | 17 | 0.050 |
Why?
|
| Homes for the Aged | 1 | 2025 | 158 | 0.050 |
Why?
|
| Censuses | 1 | 2023 | 17 | 0.050 |
Why?
|
| Accidental Falls | 1 | 2025 | 127 | 0.050 |
Why?
|
| Fractures, Bone | 1 | 2025 | 142 | 0.050 |
Why?
|
| Time-to-Treatment | 1 | 2024 | 111 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2017 | 1004 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2025 | 860 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2023 | 102 | 0.050 |
Why?
|
| Biological Products | 1 | 2024 | 94 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2024 | 267 | 0.050 |
Why?
|
| Georgia | 1 | 2022 | 87 | 0.050 |
Why?
|
| Educational Status | 1 | 2023 | 275 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 35 | 0.050 |
Why?
|
| Pain Management | 1 | 2024 | 161 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2024 | 292 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 2671 | 0.050 |
Why?
|
| Chronic Pain | 1 | 2024 | 151 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 172 | 0.050 |
Why?
|
| Tobacco Smoking | 1 | 2021 | 20 | 0.050 |
Why?
|
| Multilevel Analysis | 1 | 2021 | 6 | 0.050 |
Why?
|
| Medically Uninsured | 1 | 2021 | 40 | 0.050 |
Why?
|
| Age of Onset | 1 | 2021 | 174 | 0.040 |
Why?
|
| Myocardial Revascularization | 1 | 2021 | 75 | 0.040 |
Why?
|
| Data Collection | 1 | 2022 | 384 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 387 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2024 | 862 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2021 | 177 | 0.040 |
Why?
|
| Cause of Death | 1 | 2021 | 221 | 0.040 |
Why?
|
| Mortality | 1 | 2021 | 160 | 0.040 |
Why?
|
| Psychometrics | 1 | 2022 | 375 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 142 | 0.040 |
Why?
|
| Patient Admission | 1 | 2021 | 193 | 0.040 |
Why?
|
| Medicare Part D | 1 | 2020 | 36 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2021 | 194 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2021 | 163 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 730 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2021 | 281 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 253 | 0.040 |
Why?
|
| Biomarkers | 1 | 2024 | 1393 | 0.040 |
Why?
|
| Aging | 1 | 2024 | 746 | 0.040 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 19 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 1645 | 0.030 |
Why?
|
| Michigan | 1 | 2017 | 43 | 0.030 |
Why?
|
| Infant | 1 | 2022 | 1648 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 886 | 0.030 |
Why?
|
| Medicaid | 1 | 2021 | 362 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1001 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 3755 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 537 | 0.030 |
Why?
|
| Survivors | 1 | 2017 | 170 | 0.030 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 115 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1274 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2015 | 122 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2019 | 519 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 564 | 0.030 |
Why?
|
| Crime | 1 | 2015 | 57 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2017 | 509 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2016 | 737 | 0.030 |
Why?
|
| Medical Records | 1 | 2015 | 137 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 1092 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 1082 | 0.030 |
Why?
|
| Epidemiological Monitoring | 1 | 2013 | 31 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 1553 | 0.030 |
Why?
|
| Poverty | 1 | 2015 | 296 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 2162 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 734 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 419 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2014 | 217 | 0.020 |
Why?
|
| Health Surveys | 1 | 2013 | 313 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 391 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 847 | 0.020 |
Why?
|
| Los Angeles | 1 | 2010 | 12 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 2066 | 0.020 |
Why?
|
| State Government | 1 | 2010 | 32 | 0.020 |
Why?
|
| Commerce | 1 | 2010 | 56 | 0.020 |
Why?
|